“I can’t see how this is done, frankly, before the middle of next year,” said one expert, of a coronavirus vaccine.
. And as Democrats have argued, a faulty vaccine could cripple the country’s ability to ultimately defeat the coronavirus by destroying Americans’ remaining faith in vaccination.
Murray published a report on July 13 that expressly asked the administration to set rigorous standards for vaccine development and scientific review. The report calls on, among other things, the administration to protect the clinical review process from “political interference” and “require inclusive clinical trial designs, and engage with the international community.” Murray’s hoping Congress will introduce similar language in the coronavirus stimulus package Congress is currently negotiating.
“You need to plan now,” Murray told BuzzFeed News. “If a vaccine is available and it’s safe and effective in October, you have to have a supply chain ready. You have to have the distribution points in place. People need to know where to go. People need to know who can take and who gets it first. We need to have the plan in place and we need to have a transparent process of this vaccine and what’s going on.”A man stands outside Moderna headquarters in Cambridge, Massachusetts on May 18, 2020.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Poor nations left out as rich countries rush to secure Covid-19 vaccinesAs wealthy nations ensure themselves a sufficient supply of vaccines, there are concerns the hoarding could lead to vaccine nationalism and a shortage for others.
Weiterlesen »
Vaccine Candidate Delivers Protection In A Single Shot (In Monkeys)Two new studies involving monkeys suggest COVID-19 vaccine candidates can provide disease protection after a single injection — but it will take large-scale human trials to know for sure if they work.
Weiterlesen »
U.S. Reaches $2.1 Billion Deal With Sanofi, GlaxoSmithKline For COVID-19 Vaccine PushThe federal government has reached a deal worth up to $2.1 billion with drugmakers Sanofi and GlaxoSmithKline for another coronavirus vaccine candidate.
Weiterlesen »
U.S. To Spend $2.1 Billion On GlaxoSmithKline-Sanofi Covid-19 VaccineThe U.S. agreed to spend $2.1 billion on a joint experimental Covid-19 vaccine from GlaxoSmithKline and Sanofi to supply the nation with an initial 100 million doses by iamsternlicht
Weiterlesen »
In race for vaccine, African countries fear coming in lastLocal officials and international organizations are working to ensure a future coronavirus vaccine is distributed equitably.
Weiterlesen »